MILLENNIUM MANAGEMENT LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$82,134
-62.3%
269,293
-13.1%
0.00%
Q2 2023$218,100
+1817400.0%
309,801
+2143.6%
0.00%
Q1 2023$12
-98.7%
13,808
-98.2%
0.00%
-100.0%
Q4 2022$905
-99.2%
767,121
+4328.8%
0.00%
Q3 2021$116,000
-90.3%
17,321
-87.2%
0.00%
-100.0%
Q1 2021$1,194,000
-36.7%
134,865
-12.2%
0.00%0.0%
Q4 2020$1,887,000
+2044.3%
153,542
+1092.3%
0.00%
Q1 2020$88,000
-74.0%
12,878
-43.3%
0.00%
Q4 2019$339,000
-88.6%
22,721
-89.3%
0.00%
-100.0%
Q1 2019$2,970,000
+1064.7%
212,430
+747.3%
0.00%
Q4 2018$255,000
-70.7%
25,072
-64.9%
0.00%
-100.0%
Q2 2018$871,000
+67.5%
71,371
+91.5%
0.00%0.0%
Q4 2017$520,000
-5.5%
37,265
-25.5%
0.00%0.0%
Q3 2017$550,000
+50.7%
49,997
+8.1%
0.00%0.0%
Q2 2017$365,00046,2340.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$6,144,0004.00%
P.A.W. CAPITAL CORP 380,000$3,363,0002.96%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,770,0001.78%
Telemetry Investments, L.L.C. 150,477$1,332,0001.51%
683 Capital Management, LLC 2,683,600$23,750,0001.26%
KNOTT DAVID M 276,535$2,447,0001.05%
Trellus Management Company, LLC 226,000$2,000,0001.04%
TOWERVIEW LLC 140,000$1,239,0000.77%
Vivo Capital, LLC 1,791,257$15,853,0000.56%
CAXTON CORP 94,083$833,0000.54%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders